WHO granting emergency-use licence (EUL) to India's homegrown jab could enable the world to step up its fight against the virus if Bharat Biotech is able to improve its production capacity.
This fiscal comfort should be used by the government to ramp up the budgeted spending in the coming months, which had remained subdued in the first few months of the fiscal year.
No comments:
Post a Comment